Abstract:Glycaemia concentrations are rapidly rising globally. Abnormal glucose concentrations are associated with significantly increased risks of cardiovascular disease (CVD). 3 It has been reported that CVD has become highly prevalent in people with hyperglycaemia in western countries, but the relative evidence is lacking in China. The data on trends of CVD prevalence in the Chinese population with hyperglycaemia over time are insufficient. This study aimed to estimate recent trends in the CVD prevalence of Chinese residents aged 45 years and older across the spectrum of glycaemia levels using cohort study data collected in the 2011–2012, 2013–2014 and 2015–2016 China Health and Retirement Longitudinal Study (CHARLS). This study was approved by the ethics committee of the Medical College of Soochow University in Suzhou, Jiangsu, China. CHARLS is a longitudinal cohort study that was conducted by the Institute of Social Science Survey, Peking University, and aimed to collect a high-quality, nationally representative sample of Chinese residents aged 45 years and older. The individuals were followed up every 2 years. Demographic information of residents was obtained by a face-to-face computer-assisted personal interview. Data regarding anthropometrics, blood pressure (BP) and venous blood samples from participants after an overnight fast were collected by medically trained staff from the Center for Disease Control and Prevention of China, based on a standard protocol. The assay of blood samples used standardised laboratory techniques. All participants were asked the question: ‘Have you been diagnosed with diabetes or high blood sugar by a doctor?’ If their response was ‘Yes’, they would be defined as having diagnosed diabetes. The information on diabetes type was not collected; however, the Chinese clinical guideline for preventing diabetes reported that more than 95% of people with diabetes have type 2 diabetes in China. For those reporting no diabetes diagnosis, according to the American Diabetes Association 2013 criteria, participants were defined as having undiagnosed diabetes if they had a fasting plasma glucose (FPG) level of 126mg/dl or higher or a glycosylated haemoglobin (HbA1c) level of 6.5% or higher, prediabetes if they had a FPG of 100–125mg/dl or HbA1c of 5.7–6.4%, and normal glycaemic status if they had a FPG of less than 100mg/dl and a HbA1c of less than 5.7%. Participants who reported having diagnosed hypertension or who had an average measured systolic BP of 140mmHg or greater or diastolic BP of 90mmHg or greater, or both, were defined as having hypertension. We defined dyslipidaemia as self-reported or measured low-density lipoprotein cholesterol greater than 130mg/dl or higher. Heart disease and stroke were described on the basis of the participants’ self-reported information. Individuals aged 45 years and over were included in our study. Missing data ranged from 0.06% (drinking status) to 15.8% (waist-to-height ratio), and sample size was reduced because data for some dependent variables were missing. To account for differential probabilities of selection and non-response, appropriated published sample weights (i.e. interview weights for individuals with diagnosed diabetes, and FPG weights for individuals without diagnosed diabetes) were applied so that

Prevalence of Cardiovascular Disease and Risk Factors in the Chinese Population with Impaired Glucose Regulation: the 2007-2008 China National Diabetes and Metabolic Disorders Study

Abstract 011: Prevalence and Control of Diabetes in Chinese Adults: the China Metabolic Risk Factor Study

The Cardiometabolic Risk Profile of Chinese Adults with Diabetes: A Nationwide Cross-Sectional Survey

Glycemic Control Rate of T2DM Outpatients in China: A Multi-Center Survey

Cardiovascular Disease Burden of Chinese Middle-Aged and Elderly People Across the Spectrum of Glycaemia Levels

Prevalence of Metabolic Syndrome (mets) in Chinese Subjects Gradually Increased with Impaired Glucose Homeostasis: A Multicenter, Clinical Based, Cross-Sectional Study

A Prospective Study of Impaired Fasting Glucose and Type 2 Diabetes in China the Kailuan Study

Associations Of Blood Glucose And Prevalent Diabetes With Risk Of Cardiovascular Disease In 500 000 Adult Chinese: The China Kadoorie Biobank

Prevalence of Diabetes among Men and Women in China.

Prevalence and Clustering of Metabolic Risk Factors for Type 2 Diabetes among Chinese Adults in Shanghai, China

Prevalence and Risk Factors of Diabetes Mellitus: a Community-Based Sectional Survey.

Prevalence and risk factors for diabetes and impaired fasting glucose in Northeast China: Results from the 2016 China National Stroke Screening Survey

Epidemiological Characteristics of Diabetes Mellitus and Impaired Glucose Regulation in a Chinese Adult Population: the Shanghai Diabetes Studies, a Cross-Sectional 3-Year Follow-Up Study in Shanghai Urban Communities.

Individual and Combined Cardiometabolic Morbidities and the Subsequent Risk of Cardiovascular Events in Chinese Adults.

Risks and Population Burden of Cardiovascular Diseases Associated with Diabetes in China: A Prospective Study of 0.5 Million Adults.

Prevalence and Control of Diabetes in Chinese Adults

Cardiovascular Risk Profile and Clinical Characteristics of Diabetic Patients: a Cross-Sectional Study in China.

Disparities in high fasting plasma glucose-related cardiovascular disease burden in China

The Association of Dysglycaemia and Cardiovascular Disease in Patients with Metabolic Syndrome

Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes: a national representative population study

Prevalence of cardiovascular disease risk factors in Chinese patients with type 2 diabetes mellitus, 2013-2018